12:00 AM
 | 
Feb 06, 2012
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Cel-Sci completes direct public offering

Cel-Sci Corp. (NYSE-A:CVM), Vienna, Va.
Business: Cancer, Infectious
Date completed: 1/26/12
Type: Direct public offering...

Read the full 52 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >